Moving an API to a new site often fails because the process depends on conditions specific to the original site. Some of these conditions are technical, such as reactor size or a supplier's impurity profile. Others sit with people and systems, such as operator habits or how deviations get handled. A new site changes these conditions, and results that looked stable begin to drift. Each surprise at that stage can delay validation and, with it, commercial supply. Catching these surprises early depends on knowing where the process leans on the sending site.
Why Do API Tech Transfer Problems Stay Hidden Until the Receiving Site?
These problems stay hidden because the sending site only ever runs the process under one set of conditions. Its equipment and raw material suppliers stay the same from batch to batch. Any weakness that depends on those conditions, therefore, never gets a chance to appear.
The transfer package does little to expose these weaknesses. It records what the process needs, such as set points and specifications. It rarely records how far each setting can move before quality suffers. Say a step calls for holding a mixture at 5°C for two hours. The document may not say whether 8°C or three hours would still work.
That is the question strong API process development answers. It works out which settings affect quality and tests how far each one can move. The receiving team then gets safe ranges to work within, which makes changes easier to handle.
Without those ranges, the new team can only copy the original numbers. That works fine until something changes and someone has to make a call. And in most API tech transfer projects, something changes right away, like the reactor size or a solvent supplier. So the receiving site ends up being the first real test of how well the process holds up.
What Are the 6 Blind Spots That Surface During API Tech Transfer?
Six blind spots commonly surface once an API tech transfer reaches the new site. Three of them are technical issues that appear when the chemistry meets different equipment and materials. The other three involve people and quality systems, and they appear once the new team takes over.
1. Different Reactors Change How Reactions Behave
Reactors at the receiving site are often larger or shaped differently, and the chemistry feels that change quickly. A bigger vessel has less cooling surface for its volume, so reaction heat builds up faster. Mixing also suffers, because a larger tank blends more slowly and leaves pockets where one reagent sits in excess. Additions and heating steps stretch out as well, giving side reactions more time to run. As a result, the same set points can yield more impurities or a reaction that is harder to control.
2. New Filtration and Drying Equipment Changes the Final Solid
The reactor is only half the story, because most APIs leave the plant as a solid. That solid takes its shape during crystallization and drying, and both depend on equipment. At a new site, a different cooling rate or stirrer design can change how crystals grow. The resulting particles may flow or dissolve differently, and occasionally a new crystal form appears. Even when the form holds, finer particles can clog filters and slow each batch, putting supply schedules at risk.
3. Local Raw Material Sources Bring New Impurities
Even with the right equipment, the chemistry still depends on what goes into it. Receiving sites often switch to regional suppliers for starting materials and solvents. These materials may meet the same specification yet carry different trace impurities. Because the original route was built to remove known impurities, new ones can slip through.
Recovered solvents raise the risk further when residues carry over from other processes. For this reason, industry guidance on nitrosamine risk names starting materials and solvents as sources to check. In an API tech transfer, a supplier change can therefore bring in an impurity that the process has never faced.
4. Operator Know-How Stays at the Sending Site
Beyond equipment and materials, every process also relies on the judgment of the people running it. Experienced operators know when a mixture looks ready to filter or when a solid needs an extra wash. They also spot the color change that tells them a reaction has finished. A new team at the receiving site lacks those cues, so it follows the written steps exactly. Where a step needs judgment, that can mean a lower yield or an off-specification batch. The knowledge still exists, but it stays with operators who no longer run the process.
5. Test Methods Give Different Results on New Instruments
Once batches start, the receiving lab has to confirm they meet the specifications. In an API tech transfer, the test methods move too, and they can behave differently on new equipment. A different instrument model or testing column can change how clearly impurities separate. Reference standards from a new batch may also give slightly different readings. Together, these small shifts produce results that drift from the sending site's history. Because the drift can look like a process failure, teams may spend weeks adjusting the wrong thing.
6. Quality Systems Handle Deviations and Changes Differently
When results drift or a batch fails, the receiving site's quality system decides what happens next. Each site has its own habits here, so a quick closure at one site may mean a full investigation at another. Transfer packages don’t cover these habits, so the mismatch surfaces only in daily work. Batch release slows first, and weak handling can later draw regulatory attention. That matters because regulators often review the receiving site's quality record before approving a site change.
FDA's FY2025 Report on the State of Pharmaceutical Quality analyzed nearly 10,000 applications and supplements needing a facility assessment. As of May 2026, 28% had received a Complete Response Letter, and 43% of those came from facility-related holds. Weak investigations and missing quality unit approval for changes ranked among the top citations behind these holds.
How Can Companies Catch These Blind Spots Before the First API Tech Transfer Batch?
Companies can catch most of these blind spots before any GMP batch runs. They do it by testing each part of the API tech transfer on paper and at a small scale first. Each check below targets one of the six blind spots, while fixes are still quick and cheap:
Compare reactor performance with lab data: Check the new reactor's cooling capacity and mixing against what the reaction needs. Adjust addition times before the first scale-up run.
Run small isolation trials on the new equipment: Confirm that particle size and crystal form match the original API.
Test new supplier lots side by side: Run them through the process next to reference lots and compare impurity profiles.
Pair operators from both sites: Have sending-site operators join the first trial runs at the new site. Then add their practical cues to the batch record.
Test the same samples in both labs: Matching results confirm the method works on new instruments before processing data that depends on it.
Agree on quality rules upfront: Settle how deviations are investigated and who approves changes before the first batch.
Finally, check the receiving site's FDA inspection record before the transfer starts. A compliant site helps a well-run API tech transfer avoid delays at approval.
FAQs
1. What should a tech transfer package include?
A tech transfer package should explain why the process works, along with how to run it. Instructions alone leave a new team guessing when something goes wrong.
A useful package usually covers:
Development reports explaining why each step and condition was chosen
Impurity data showing where each impurity forms and which step removes it
Validation reports and reference standards for every test method
Batch history, including past deviations and how each one was resolved
Stability data for the API and its key intermediates
2. How many batches does the receiving site need to make?
There is no fixed number of batches the receiving site must make. FDA's process validation guidance asks companies to justify the number using process knowledge and risk.
A well-understood process with strong development data may need fewer batches. A process with limited data or major equipment changes usually needs more. Many companies still run three validation batches.
3. Do regulators need to approve a new API manufacturing site?
In most markets, regulators need to be told about a new API manufacturing site. Moving production counts as a change to the approved application. The filing route depends on the market and the risk of the change:
United States: A supplement to the approved application, with the filing type based on risk
European Union: a variation to the marketing authorization
Japan: A partial change application or a minor change notification
Some filings need approval before the new site can ship commercial material. Planning the filing early keeps it from holding up supply.
4. Can the process be improved during the transfer?
Yes, a process can be improved during a transfer, but every change adds extra work. A new step or setting may need more testing and a fresh regulatory filing.
That is why many companies first move the process unchanged. They make improvements later, one at a time, once the new site runs smoothly. This way, if results change, the cause is easy to find. A change can still go into the transfer if it is well-tested and needs no extra filing.
Copyright © 2026 California Business Journal. All Rights Reserved.
For California Business Journal Disclaimers, go to https://calbizjournal.com/terms-conditions/.
